The Perfect Holiday Gift Gift Now

INDIA'S CVD PUZZLE DECODED

Healthcare Radius

|

December 2023

Get insights from top industry experts on cardiovascular diseases (CVDs) in India-their prevalence, interplay with other conditions, diagnostic complexities, cardiac rehabilitation, and more

INDIA'S CVD PUZZLE DECODED

Cardiovascular diseases (CVDs), including conditions like ischaemic heart disease and stroke, are responsible for nearly 1.77 crore fatalities, making them the primary cause of death globally. According to the World Health Organization, India contributes to a major share of these deaths. As per the Global Burden of Disease study, the age-standardized CVD death rate in India is 272 per one lakh population, which exceeds the global average of 235 per one lakh.

This cover story is in the form of a collection of thought leadership articles by top industry experts who have provided readers with a comprehensive exploration into the multifaceted landscape of CVDs. Each piece delves into the finer aspects related to CVDs and collectively shed light on complexities, their interaction with various comorbidities, environmental factors, technological advancements, and regional disparities.

In India, CVDs are more than a health concern; they represent an intricate tapestry woven with interconnected threads of diabetes, hypertension, obesity, chronic kidney disease, and mental health disorders. This article collection highlights the regional disparities and varied risk factors impacting different demographics in India. It underscores the need for collaborative efforts and interventions for detection, prevention, and treatment of CVDs. Get a panoramic view of India's cardiovascular health challenges and delve deep into the interconnected nature of these conditions in the next few pages. Discover the solutions offered by the industry experts to take India's CVD-challenge head-on.

Tackling India's CVD diagnostic challenge

India's diverse landscape complicates cardiovascular disease diagnosis, requiring a nuanced, collaborative healthcare approach.

DR ABHAY SOMANI

WEITERE GESCHICHTEN VON Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Translate

Share

-
+

Change font size